Evaluating the innovative potential of the global antibacterial pipeline
Clinical Microbiology and Infection · 2025-06 · 31 (6) · 903-909
DOI: 10.1016/j.cmi.2023.09.024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2025-06. Verfasst von Ursula Theuretzbacher. Beteiligte Einrichtung: Center for Anti-Infective Agents, Vienna, Austria. Electronic address: utheuretzbacher@cefaia.com. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Bacteria, Bacterial Infections. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Anti-Infective Agents, Vienna, Austria. Electronic address: utheuretzbacher@cefaia.com.
Zitieren
APA
Theuretzbacher, U. (2025). Evaluating the innovative potential of the global antibacterial pipeline. Clinical Microbiology and Infection, 31(6), 903-909. https://doi.org/10.1016/j.cmi.2023.09.024
Vancouver
Theuretzbacher U. Evaluating the innovative potential of the global antibacterial pipeline. Clinical Microbiology and Infection. 2025;31(6):903-909. doi:10.1016/j.cmi.2023.09.024
BibTeX
@article{Theuretzbacher2025,
author = {Theuretzbacher, Ursula},
title = {Evaluating the innovative potential of the global antibacterial pipeline},
journal = {Clinical Microbiology and Infection},
year = {2025},
volume = {31},
number = {6},
pages = {903--909},
doi = {10.1016/j.cmi.2023.09.024}
}
EUVIMED